EUROPEAN JOURNAL OF HEART FAILURE

Scope & Guideline

Shaping the future of cardiology with impactful discoveries.

Introduction

Welcome to your portal for understanding EUROPEAN JOURNAL OF HEART FAILURE, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1388-9842
PublisherWILEY
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1999 to 2024
AbbreviationEUR J HEART FAIL / Eur. J. Heart Fail.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The European Journal of Heart Failure focuses on the latest advances in heart failure research, treatment, and management. It serves as a crucial platform for disseminating innovative findings and clinical practices that contribute to improving patient outcomes in heart failure management.
  1. Heart Failure Mechanisms and Pathophysiology:
    Research exploring the biological mechanisms underlying heart failure, including genetic, molecular, and cellular factors that contribute to disease progression.
  2. Clinical Management and Treatment Strategies:
    Studies evaluating the efficacy and safety of various treatment modalities, including pharmacological therapies, device interventions, and lifestyle changes for heart failure patients.
  3. Epidemiology and Risk Factors:
    Investigations into the prevalence, incidence, and risk factors associated with heart failure across different populations, with an emphasis on comorbidities and demographic influences.
  4. Diagnostic Approaches:
    Research focused on the development and validation of diagnostic tools and biomarkers for the early detection and accurate classification of heart failure.
  5. Health Economics and Patient Outcomes:
    Analysis of healthcare resource utilization, cost-effectiveness of treatments, and the impact of heart failure on quality of life and long-term outcomes.
  6. Innovative Technologies:
    Studies on the application of new technologies, such as telemedicine, remote monitoring, and machine learning, to enhance heart failure management and patient care.
The journal has identified several trending themes that reflect the evolving landscape of heart failure research and clinical practice. These emerging topics may offer new insights and directions for future studies.
  1. Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors:
    A notable increase in research surrounding SGLT2 inhibitors as a treatment option for heart failure, highlighting their multifaceted benefits beyond glycemic control.
  2. Heart Failure with Preserved Ejection Fraction (HFpEF):
    Growing attention on HFpEF, with an emphasis on understanding its unique pathophysiology, diagnostic criteria, and treatment challenges.
  3. Telemedicine and Remote Monitoring:
    Emerging themes in the utilization of telemedicine and remote monitoring technologies for managing heart failure, particularly in light of the COVID-19 pandemic.
  4. Machine Learning and Artificial Intelligence:
    Increasing integration of machine learning and AI in predicting heart failure outcomes, enhancing diagnostics, and personalizing treatment strategies.
  5. Comorbidities and Multimorbidity:
    A trend towards understanding the interplay between heart failure and other chronic conditions, focusing on comprehensive care approaches that address multiple comorbidities.
  6. Patient-Centered Care and Quality of Life:
    A shift towards research that emphasizes patient-reported outcomes, quality of life assessments, and the psychosocial aspects of living with heart failure.

Declining or Waning

While the journal has seen a surge in certain themes, some areas of focus appear to be declining. This shift may reflect changes in clinical priorities or emerging research interests.
  1. Traditional Pharmacotherapy Alone:
    There seems to be a diminishing focus on studies solely centered around traditional pharmacological treatments for heart failure, with increasing interest in combination therapies and innovative approaches.
  2. Generalized Heart Failure Definitions:
    The use of broad, non-specific definitions of heart failure is becoming less prominent, as more precise phenotyping and tailored approaches are being favored in recent research.
  3. Single-Center Studies:
    The prevalence of single-center studies is declining in favor of multi-center and large cohort studies, which provide more generalizable findings and insights into heart failure management.
  4. Basic Science without Clinical Relevance:
    Research that lacks direct clinical applicability or insights into patient care is receiving less attention, as the journal increasingly prioritizes studies that bridge laboratory findings with clinical implications.

Similar Journals

CARDIOVASCULAR RESEARCH

Connecting research to real-world cardiovascular solutions.
Publisher: OXFORD UNIV PRESSISSN: 0008-6363Frequency: 18 issues/year

CARDIOVASCULAR RESEARCH, published by Oxford University Press, is a premier academic journal dedicated to the evolving field of cardiology and cardiovascular medicine. With a remarkable impact factor reflecting its significant contribution to the scientific community, this journal maintains a Q1 ranking in both Cardiology and Physiology categories, demonstrating its commitment to publishing high-quality research that influences clinical practices and healthcare outcomes. Established in 1967, the journal has consistently provided a platform for innovative studies and reviews, aiming to advance our understanding of cardiovascular physiology and pathology. Researchers, professionals, and students will find published articles crucial for their work, as the journal covers a broad spectrum of topics including molecular biology, genetics, and clinical studies. While currently not offering open access options, CARDIOVASCULAR RESEARCH remains accessible through institutional and individual subscriptions, ensuring that the latest findings are available to those in the cardiovascular science community.

HEART AND VESSELS

Exploring Innovations in Cardiology and Vascular Medicine
Publisher: SPRINGERISSN: 0910-8327Frequency: 12 issues/year

HEART AND VESSELS is a prominent peer-reviewed journal published by SPRINGER, dedicated to advancing the fields of cardiology and cardiovascular medicine. With its ISSN 0910-8327 and E-ISSN 1615-2573, this esteemed journal encompasses a broad range of topics pertinent to heart health, vascular function, and associated therapies, making it an essential resource for researchers, clinicians, and healthcare professionals alike. Based in Japan and operating since 1985, HEART AND VESSELS has consistently maintained a Q2 ranking in the 2023 category quartiles, highlighting its relevance and impact in the cardio domain. Although it does not offer open access, the journal ensures high-quality publications that contribute significantly to the academic and clinical understanding of cardiovascular health. With over three decades of continuous scholarly contribution, HEART AND VESSELS serves as a vital platform for disseminating cutting-edge research and fostering innovative practices in the management of cardiovascular diseases.

Anatolian Journal of Cardiology

Fostering Cardiovascular Excellence Since 2001.
Publisher: KARE PUBLISSN: 2149-2263Frequency: 12 issues/year

The Anatolian Journal of Cardiology, published by KARE PUBL, stands as a vital resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 2149-2263 and E-ISSN 2149-2271, this Open Access journal has been fostering the dissemination of critical research since 2001, ensuring that high-quality content is freely available to a global audience. Based in Turkey, the journal aims to bridge gaps in cardiological knowledge through rigorous peer-reviewed articles that span a wide range of topics, from innovative clinical practices to groundbreaking research findings. While its current ranking places it in the Q3 category of cardiology journals, the Anatolian Journal of Cardiology continues to strive towards enhancing its impact, currently holding a Scopus rank of 236 out of 387. Researchers, practitioners, and students alike will find this journal an essential platform for keeping abreast of the latest developments in cardiovascular health.

Current Heart Failure Reports

Delivering Essential Research for Cardiovascular Care
Publisher: SPRINGERNATUREISSN: 1546-9530Frequency: 6 issues/year

Current Heart Failure Reports, published by SpringerNature, is a leading journal dedicated to advancing the field of cardiology, specifically focusing on heart failure. With an impressive impact factor and a recognized reputation, this journal falls under the top quartiles in several categories, including Q1 in Cardiology and Cardiovascular Medicine and Emergency Medicine. Its range of topics encompasses both clinical and research insights into heart failure management, offering valuable perspectives aligned with the latest therapeutic advancements. Although it does not have open access options, researchers and practitioners can find profound studies and reviews aimed at improving patient care and outcomes in cardiovascular health. As the journal converges towards its 20th year in print, it continues to serve as a critical resource for academic professionals, providing a platform for high-quality research that shapes the future of heart failure treatments.

Netherlands Heart Journal

Advancing Cardiovascular Knowledge for a Healthier Tomorrow
Publisher: BOHN STAFLEU VAN LOGHUM BVISSN: 1568-5888Frequency: 12 issues/year

Netherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.

REVISTA ESPANOLA DE CARDIOLOGIA

Exploring the Frontiers of Heart Health
Publisher: EDICIONES DOYMA S AISSN: Frequency: 12 issues/year

REVISTA ESPANOLA DE CARDIOLOGIA is a premier journal dedicated to the dynamic field of cardiology, published by EDICIONES DOYMA S A in Barcelona, Spain. With an impressive Q1 status in the Medicine (miscellaneous) category for 2023, this journal is recognized for its significant contributions to cardiovascular research, evidenced by its rank of #61 out of 387 in the Scopus database, placing it within the top 16% of journals in its field. Covering a broad range of topics within cardiology, the journal aims to disseminate high-quality research, clinical studies, and educational content, fostering knowledge sharing among researchers, clinicians, and students alike. While it does not currently offer open access, the journal maintains a commitment to advancing cardiovascular health through rigorous peer-reviewed articles. With a publication history that spans from 2013 to 2024, REVISTA ESPANOLA DE CARDIOLOGIA is an essential resource for those seeking to stay at the forefront of cardiology advancements and practices.

Circulation-Heart Failure

Elevating the standard of cardiovascular medicine.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1941-3289Frequency: 12 issues/year

Welcome to Circulation-Heart Failure, a leading peer-reviewed journal published by Lippincott Williams & Wilkins dedicated to advancing the field of cardiac biology and clinical cardiology. With an impressive impact factor and ranked in the Q1 category both in Cardiology and Cardiovascular Medicine and in Medicine (miscellaneous), this journal stands out as a vital resource for researchers, clinicians, and students. Since its inception in 2008, Circulation-Heart Failure has been at the forefront of disseminating innovative research, expert reviews, and clinical practices related to heart failure and cardiovascular health. The journal, housed in the United States, is committed to fostering a deeper understanding of heart failure management, offering regular issues that converge comprehensive studies, cutting-edge clinical insights, and the latest advancements in therapeutic strategies. Engage with the latest findings and contribute to the dialogue in a journal recognized for its rigorous standards and significant contributions to the cardiology community.

CURRENT PROBLEMS IN CARDIOLOGY

Navigating Today's Cardiology Dilemmas
Publisher: MOSBY-ELSEVIERISSN: 0146-2806Frequency: 12 issues/year

CURRENT PROBLEMS IN CARDIOLOGY is a leading peer-reviewed journal published by MOSBY-ELSEVIER, dedicated to advancing the field of cardiology through comprehensive analyses of contemporary challenges faced by cardiovascular practitioners. With its ISSN 0146-2806 and E-ISSN 1535-6280, this esteemed journal has been a crucial resource for researchers, clinicians, and students alike since its inception in 1976, and continues to publish groundbreaking studies and reviews up until 2024. As a testament to its scholarly impact, CURRENT PROBLEMS IN CARDIOLOGY boasts a prestigious Q1 ranking in both Cardiology and Cardiovascular Medicine, as well as in the broader category of Medicine (miscellaneous) in the 2023 metrics, positioning it among the top journals in its field. With a Scopus ranking of #127 out of 387 in Cardiology, and a 67th percentile ranking, it remains a vital platform for disseminating high-quality research that addresses critical issues in cardiovascular health. Researchers and practitioners looking to stay at the forefront of cardiac medicine will find this journal an indispensable tool for informed decision-making and practice improvement.

Cardiovascular Innovations and Applications

Bridging the gap between research and practice in cardiovascular medicine.
Publisher: COMPUSCRIPTISSN: 2009-8618Frequency: 1 issue/year

Cardiovascular Innovations and Applications is a premier open-access journal dedicated to advancing knowledge in the field of cardiovascular medicine. Published by COMPUSCRIPT since 2016, this journal provides a platform for the dissemination of innovative research and applications that address crucial topics in cardiology, aiming to bridge the gap between clinical practice and cutting-edge research. With an ISSN of 2009-8618 and an E-ISSN of 2009-8782, it operates on a global scale, facilitating access to high-quality content without financial barriers. The journal is positioned within the Medicine - Cardiology and Cardiovascular Medicine category, and its current Scopus rank of #321/387 reflects its potential for growth and influence in the academic community, being in the 17th percentile. Researchers, healthcare professionals, and students will find Cardiovascular Innovations and Applications an invaluable resource in their quest for the latest findings and advancements in cardiovascular health and treatment methodologies.

Journal of Cardiology

Exploring the frontiers of heart health and innovation.
Publisher: ELSEVIERISSN: 0914-5087Frequency: 12 issues/year

Journal of Cardiology, published by ELSEVIER, stands as a prominent resource in the field of cardiology and cardiovascular medicine. With a rich history since its inception in 1987, this peer-reviewed journal aims to disseminate cutting-edge research that enhances the understanding and treatment of cardiovascular diseases. Its 2023 ranking places it in the Q2 category within its discipline, reflecting its significance and impact, as evidenced by a Scopus rank of #123 out of 387 journals, positioning it in the 68th percentile of its field. The journal is headquartered in Japan, providing a unique perspective on cardiological advances relevant not only to the Asian continent but also globally. Though it does not currently offer open access, the Journal of Cardiology remains a vital institutional resource for researchers, clinicians, and students seeking to push the boundaries of cardiovascular science and improve patient outcomes.